5-Amino-1MQ
Research-Grade
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme overexpressed in obese adipose tissue and aged skeletal muscle. NNMT inhibition is theorized to divert methyl groups back toward productive cellular methylation reactions, increase NAD+ availability, and improve metabolic function. Preclinical data is encouraging: mice on high-fat diets show significant weight reduction, improved insulin sensitivity, and reduced adipose expansion with 5-Amino-1MQ treatment. Muscle-regeneration studies in aged mice have reported improved stem-cell function and faster recovery. Human data is essentially absent. The molecule is frequently marketed and discussed alongside peptides in fat-loss contexts, but strictly speaking it is a small molecule, not a peptide. It is included here for completeness.
Specifications
| Origin / Manufacturer | Synthetic small molecule |
| Form Factor | Capsule or lyophilized powder |
Frequently Asked Questions
Sources & References
Every clinical claim on this page traces to a primary peer-reviewed source.
- 1Neelakantan H, Vance V, Wetzel MD, et al.. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochemical Pharmacology. 2018;147:141-152. doi:10.1016/j.bcp.2017.11.007 PMID:29158069
Reviewed by
Clinical Research Review Board
Pharmacology & Endocrinology Review
All clinical claims cross-checked against primary sources. Read our editorial policy →